Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Uncertainty over TikTok’s U.S. future splinters creators and agencies
With the possible removal of TikTok in the U.S. as early as January, creators and agencies fall on both sides of the issue: either believing it will happen or confident that the ban won’t go through in the end
In Graphic Detail: How Sia’s Clip It launch shows the power of Roblox for musicians
Sia’s Clip It integration into Roblox is the first time a prominent mainstream musical artist has placed their music and branding inside the space.
Marketers have a new audience to worry about — large language models
Tech firms are creating new ways to understand how large language models perceive their brands.